Skip to main content
Top

Journal of Gastrointestinal Cancer

Issue 1/2014

Content (22 Articles)

Review Article

Could Signal Transducer and Activator of Transcription 3 be a Therapeutic Target in Obesity-Related Gastrointestinal Malignancy?

Katie E. O’Sullivan, John V. Reynolds, Ciara O’Hanlon, Jacintha N. O’Sullivan, Joanne Lysaght

Review Article

Hereditary Pancreatitis: Dilemmas in Differential Diagnosis and Therapeutic Approach

Aikaterini Mastoraki, Adelais Tzortzopoulou, Smaragda Tsela, Nikolaos Danias, George Sakorafas, Vasilios Smyrniotis, Nikolaos Arkadopoulos

Original Research

Efficacy of Endoscopic Submucosal Dissection for Cancer of the Operated Stomach

Junichi Nishimura, Jun Nishikawa, Kouichi Hamabe, Munetaka Nakamura, Atsushi Goto, Takeshi Okamoto, Osamu Miura, Isao Sakaida

Original Research

Mutational and Clinical Predictors of Pathologic Complete Response in the Treatment of Locally Advanced Rectal Cancer

Andrea L. Russo, David P. Ryan, Darrell R. Borger, Jennifer Y. Wo, Jackie Szymonifka, Wen-Yih Liang, Eunice L. Kwak, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Jill N. Allen, Andrew X. Zhu, David L. Berger, James C. Cusack, Harvey J. Mamon, Kevin M. Haigis, Theodore S. Hong

Original Research

Role of hMLH1 and E-Cadherin Promoter Methylation in Gastric Cancer Progression

Meysam Moghbeli, Omeed Moaven, Bahram Memar, Hamid Reza Raziei, Azadeh Aarabi, Ezzat Dadkhah, Mohammad Mahdi Forghanifard, Fatemeh Manzari, Mohammad Reza Abbaszadegan

Original Research

Prognostic Value of Tumor-Infiltrating Mast Cells in Outcome of Patients with Esophagus Squamous Cell Carcinoma

Ashraf Fakhrjou, Seid Mahdi Niroumand-Oscoei, Mohamad Hosein Somi, Morteza Ghojazadeh, Shahnaz Naghashi, Shabnam Samankan

Original Research

Expression of MT2 Receptor in Patients with Gastric Adenocarcinoma and its Relationship with Clinicopathological Features

Nafiseh Nasri Nasrabadi, Ramin Ataee, Saeid Abediankenari, Mohammad Shokrzadeh, Mojtaba Najafi, Seyed Vahid Hoseini, Hamed Haghi Amin Jan

Original Research

Clinical Outcomes of Stenting for Colorectal Obstruction at a Tertiary Centre

Tyler Alford, Sunita Ghosh, Clarence Wong, Daniel Schiller

Original Research

ERCC1 in Advanced Biliary Tract Cancer Patients Treated with Chemotherapy: Prognostic and Predictive Roles

Vanessa da Costa Miranda, Maria Ignez Braghiroli, Luiza Dib Batista Bugiato Faria, Sheila Aparecida Coelho Siqueira, Jorge Sabbaga, Paulo M. Hoff, Rachel P. Riechelmann

Case Report

Ampulla of Vater Adenocarcinoma in a BRCA2 Germline Mutation Carrier

Nana Aburjania, Alexander M. Truskinovsky, Michael J. Overman, Emil Lou

Case Report

IgM Monoclonal Gammopathy in Gastric MALToma

Zhineng J. Yang, Gurprataap S. Sandhu, Nidhi Aggarwal, Kenneth E. Fasanella, Mounzer Agha

Case Report

Recurrent Gastric Cancer Presenting with Both Scrotal and Facial Skin Metastases: A Case Report

Faruk Tas, Rumeysa Ciftci, Nesimi Buyukbabani, Senem Karabulut

Case Report

Esophageal Cancer and Dysphagia in the HIV-Positive Patient

Thomas D. Willson, Arsalan Salamat, Tracy E. Sambo, Mark M. Connolly, Francis J. Podbielski

Case Report

Extra-skeletal Osteosarcoma Presenting as a Peri-ampullary Mass

Alexander Khalaf, Matthew T. Heller

Case Report

Oxaliplatin-Induced Ototoxicity in Adjuvant Setting for Colorectal Cancer: Unusual Side Effect

Fatima Zahra Hijri, Samia Arifi, Naouar Ouattassi, Nawfal Mellas, Omar El Mesbahi

Brief Communication

Modified GTX as Second-Line Therapy for Advanced Pancreatic Adenocarcinoma

Hana Ajouz, Deborah Mukherji, Ali Haydar, Ahmad Sharif Yakan, Ahmad Saleh, Elias Elias, Sally Temraz, Walid Faraj, Mohammad Khalife, Ali Shamseddine

Letter to the Editor

Intraperitoneal Hyperthermic Chemotherapy: Which Drugs?

Jacopo Giuliani

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine